KR890007742A - 허혈성 심장 질환 치료제 - Google Patents

허혈성 심장 질환 치료제 Download PDF

Info

Publication number
KR890007742A
KR890007742A KR1019880014987A KR880014987A KR890007742A KR 890007742 A KR890007742 A KR 890007742A KR 1019880014987 A KR1019880014987 A KR 1019880014987A KR 880014987 A KR880014987 A KR 880014987A KR 890007742 A KR890007742 A KR 890007742A
Authority
KR
South Korea
Prior art keywords
heart disease
dibenzo
piperidinyl
dihydro
acetyl
Prior art date
Application number
KR1019880014987A
Other languages
English (en)
Inventor
트라흐 폴커
에버라인 볼프강
엥겔 볼프하르트
밈 게르하르트
마이어 노르베르트
두스 헨리
트룸리쯔 귄터
Original Assignee
디이터 라우디엔·게르하르트 후버
닥터 칼 토매 지엠비에이치
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디이터 라우디엔·게르하르트 후버, 닥터 칼 토매 지엠비에이치 filed Critical 디이터 라우디엔·게르하르트 후버
Publication of KR890007742A publication Critical patent/KR890007742A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

허혈성 심장 질환 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 6-클로로-5,10-디하이드로-5-[(1-메틸-4-피페리디닐)아세틸]-11H-디벤조[b,e][1,4]디아제핀-11-온 및/또는 (+)-6-클로로-5,10-디하이드로-5-[(1-메틸-4-피페리디닐)-아세틸]-11H-디벤조[b,e][1,4]디아제핀-11-온 또는 무기 또는 유기산과의 생리학적으로 허용되는 이의 염의, 허혈성 심장 질환을 치료하기 위한 용도.
  2. 6-클로로-5,10-디하이드로-5-[(1-메틸-4-피페리디닐)아세틸]-11H-디벤조[b,e][1,4]디아제핀-11-온 및/또는 (+)-6-클로로-5,10-디하이드로-5-[(1-메틸-4-피페리디닐)-아세틸]-11H-디벤조[b,e][1,4]디아제핀-11-온 또는 무기 또는 유기산과의 생리학적으로 허용되는 이의 염의, 허혈성 심장 질환 치료용 약제학적 조성물의 제조를 위한 용도.
  3. 관상 경축을 억제하기 위한 제1항 또는 2항에 따르는 화합물의 용도.
  4. 안정 및/또는 불안정 협심증을 치료하기 위한 제1항 또는 2항에 따르는 화합물의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880014987A 1987-11-17 1988-11-15 허혈성 심장 질환 치료제 KR890007742A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873738980 DE3738980A1 (de) 1987-11-17 1987-11-17 Mittel zur behandlung von ischaemischen herzerkrankungen
DEP3738980.7 1987-11-17

Publications (1)

Publication Number Publication Date
KR890007742A true KR890007742A (ko) 1989-07-05

Family

ID=6340664

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880014987A KR890007742A (ko) 1987-11-17 1988-11-15 허혈성 심장 질환 치료제

Country Status (7)

Country Link
EP (1) EP0316690A3 (ko)
JP (1) JPH01160920A (ko)
KR (1) KR890007742A (ko)
AU (1) AU2564188A (ko)
DE (1) DE3738980A1 (ko)
DK (1) DK639088A (ko)
HU (1) HU199292B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003054598A (ja) * 2001-08-08 2003-02-26 Nippon Sanso Corp 蓋付容器

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3204157A1 (de) * 1982-02-06 1983-08-11 Dr. Karl Thomae Gmbh, 7950 Biberach Substituierte dibenzodiazepinone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3531682A1 (de) * 1985-09-05 1987-03-12 Thomae Gmbh Dr K (+)-6-chlor-5,10-dihydro-5-((1-methyl-4- piperidinyl)acetyl)-11h-dibenzo(b,e)(1,4) diazepin-11-on, seine isolierung und verwendung als arzneimittel

Also Published As

Publication number Publication date
DK639088A (da) 1989-05-18
EP0316690A3 (de) 1990-10-10
HUT48465A (en) 1989-06-28
DE3738980A1 (de) 1989-05-24
EP0316690A2 (de) 1989-05-24
JPH01160920A (ja) 1989-06-23
AU2564188A (en) 1989-05-18
HU199292B (en) 1990-02-28
DK639088D0 (da) 1988-11-16

Similar Documents

Publication Publication Date Title
FR2711993B1 (fr) Médicaments contenant des dérivés de 7H-imidazol[1,2-a]pyrazine-8-one, les nouveaux composés et leur préparation.
DK57388D0 (da) Thiazolidinonderivater, fremgangsmaade til deres fremstilling samt anvendelsen heraf
DK275488A (da) Indolonderivater
OA08481A (fr) Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
KR890015742A (ko) 이병치료용 국소 제제
DK0563731T3 (da) Lægemidler indeholdende polyhydromethylenderivater, fremgangsmåde til deres fremstilling og deres anvendelse
MX9306234A (es) Oxindoles y azaoxoindoles 1-substituidos y composiciones farmaceuticas que los contienen.
KR880013555A (ko) 당뇨병의 치료방법
DE3876769D1 (de) Mikrobiologische herstellung von 9-alpha-hydroxy-17-keto-steroiden.
KR910007509A (ko) 친유성 약제용 주사 조성물
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
KR880008801A (ko) 비경구 투여용 용액제
KR890007742A (ko) 허혈성 심장 질환 치료제
FI881413A (fi) Foerfarande foer framstaellning av 3'-azido-3'-deoxitymidin.
KR880013927A (ko) 피리미딘 유도체
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
DK52685D0 (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
DE3574969D1 (de) Aetheroxidderivate von zyklopropylphenolen.
FR2628101B1 (fr) Procede d'oxydation catalytique d'alcanes en melanges d'alcools et de cetones
KR900007421A (ko) 급성 및 만성 폐쇄성 기도 질환 치료제.
KR890012960A (ko) 결정성 β-락탐 용매화물
KR880012226A (ko) 외 용 제
FI890864A0 (fi) Anvaendning av 1,4-dihydropyridinderivat.
TR199701258T1 (xx) S�bstit�e edilmi� amidinler, ila�lar ve bunlar�n �retilmesi.
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid